LAMIVUDINE AND ZIDOVUDINE

LAMIVUDINE AND ZIDOVUDINE was reported 7705 times

LAMIVUDINE AND ZIDOVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIV INFECTION CDC CATEGORY C 6 0.7500
1 DIAPHRAGMATIC APLASIA 16 0.6154
2 HEPATIC DISPLACEMENT 14 0.5833
3 METHYLMALONIC ACIDURIA 7 0.5000
4 SPINOCEREBELLAR DISORDER 18 0.3830
5 CARDIAC MALPOSITION 19 0.2500
6 CONGENITAL DIAPHRAGMATIC ANOMALY 8 0.2222
7 DANDY-WALKER SYNDROME 57 0.2201
8 ALPHA 1 FOETOPROTEIN ABNORMAL 22 0.2200
9 LACTATE PYRUVATE RATIO INCREASED 10 0.2174
10 PRENATAL SCREENING TEST ABNORMAL 11 0.2037
11 MECONIUM PERITONITIS 5 0.2000
12 PLACENTAL NECROSIS 6 0.1818
13 THALASSAEMIA ALPHA 6 0.1818
14 CONGENITAL HEPATOBILIARY ANOMALY 6 0.1765
15 MITOCHONDRIAL DNA DEPLETION 6 0.1714
16 CONGENITAL ANAEMIA 8 0.1569
17 GENETIC POLYMORPHISM 8 0.1404
18 PREMATURE CLOSURE OF CRANIAL SUTURES 5 0.1316
19 GENITAL PROLAPSE 7 0.1250
20 MECONIUM ILEUS 8 0.1212
21 CONGENITAL HEPATOMEGALY 5 0.1136
22 ADRENOGENITAL SYNDROME 15 0.1111
23 CHORIOAMNIONITIS 20 0.1053
24 MACROCEPHALY 40 0.1031
25 CEREBELLAR HYPOPLASIA 17 0.1012
26 FUNISITIS 5 0.1000
27 ULTRASOUND ANTENATAL SCREEN ABNORMAL 22 0.1000
28 AMNIOTIC CAVITY DISORDER 6 0.0923
29 BONE DEMINERALISATION 96 0.0907
30 FOETAL ALCOHOL SYNDROME 9 0.0900
31 MITOCHONDRIAL CYTOPATHY 35 0.0795
32 NORMAL DELIVERY 7 0.0787
33 DEFORMITY THORAX 15 0.0777
34 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 8 0.0721
35 FOETAL MOVEMENTS DECREASED 7 0.0686
36 ATRIOVENTRICULAR SEPTAL DEFECT 32 0.0681
37 CONGENITAL PYELOCALIECTASIS 8 0.0667
38 POLYDACTYLY 75 0.0647
39 TRISOMY 21 79 0.0627
40 NEUTROPENIA NEONATAL 13 0.0580
41 STILLBIRTH 278 0.0575
42 ACCESSORY AURICLE 4 0.0571
43 LIPODYSTROPHY ACQUIRED 120 0.0565
44 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 61 0.0564
45 NEURODEVELOPMENTAL DISORDER 37 0.0547
46 PLAGIOCEPHALY 27 0.0541
47 MENINGOMYELOCELE 32 0.0533
48 EXOMPHALOS 28 0.0521
49 HEAD CIRCUMFERENCE ABNORMAL 8 0.0516
50 BRACHYCEPHALY 5 0.0495
51 APLASIA CUTIS CONGENITA 7 0.0490
52 ENCEPHALOCELE 12 0.0482
53 CONGENITAL HYDROCEPHALUS 24 0.0473
54 CONGENITAL SKIN DIMPLES 11 0.0456
55 ADRENAL CYST 5 0.0455
56 VENTRICULAR ENLARGEMENT 8 0.0455
57 CEPHALHAEMATOMA 5 0.0450
58 INTRA-UTERINE DEATH 71 0.0442
59 VENTRICULAR HYPOPLASIA 11 0.0440
60 DIASTASIS RECTI ABDOMINIS 7 0.0435
61 ULTRASOUND SCAN ABNORMAL 17 0.0434
62 FOETAL GROWTH RETARDATION 30 0.0383
63 CONGENITAL ANOMALY IN OFFSPRING 5 0.0379
64 PREGNANCY INDUCED HYPERTENSION 6 0.0373
65 AMNIOTIC BAND SYNDROME 4 0.0364
66 CHORDEE 5 0.0355
67 LEFT VENTRICULAR ENLARGEMENT 9 0.0353
68 ANAEMIA NEONATAL 17 0.0353
69 CHOLESTASIS OF PREGNANCY 16 0.0348
70 UMBILICAL CORD VASCULAR DISORDER 5 0.0347
71 GENITALIA EXTERNAL AMBIGUOUS 6 0.0347
72 FAT REDISTRIBUTION 8 0.0345
73 VIRAL LOAD DECREASED 5 0.0342
74 DRUG EXPOSURE DURING PREGNANCY 1147 0.0337
75 BIOPSY LIVER ABNORMAL 10 0.0333
76 NEURAL TUBE DEFECT 24 0.0330
77 FEAR-RELATED AVOIDANCE OF ACTIVITIES 5 0.0329
78 CONGENITAL CHOROID PLEXUS CYST 10 0.0328
79 MALARIA 23 0.0326
80 CONGENITAL HYDRONEPHROSIS 23 0.0322
81 ULTRASOUND KIDNEY ABNORMAL 5 0.0314
82 PLACENTAL INFARCTION 7 0.0314
83 CONGENITAL DIAPHRAGMATIC HERNIA 12 0.0307
84 LIPOMATOSIS 6 0.0303
85 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 7 0.0300
86 PLACENTAL DISORDER 28 0.0296
87 PNEUMOCYSTIS CARINII PNEUMONIA 6 0.0296
88 CONGENITAL CYTOMEGALOVIRUS INFECTION 5 0.0294
89 DIAPHRAGMATIC HERNIA 18 0.0290
90 CONGENITAL FOOT MALFORMATION 13 0.0286
91 CD4 LYMPHOCYTES ABNORMAL 6 0.0286
92 PREMATURE RUPTURE OF MEMBRANES 67 0.0278
93 MATERNAL CONDITION AFFECTING FOETUS 6 0.0271
94 HIP DYSPLASIA 6 0.0271
95 VIRAL MUTATION IDENTIFIED 100 0.0271
96 CRYPTORCHISM 30 0.0267
97 CEREBRAL VENTRICLE DILATATION 30 0.0260
98 FOETAL HEART RATE DECELERATION 6 0.0259
99 ACOUSTIC STIMULATION TESTS ABNORMAL 4 0.0256
100 ANAEMIA MACROCYTIC 54 0.0253
101 CONGENITAL MUSCULOSKELETAL ANOMALY 11 0.0249
102 ANENCEPHALY 14 0.0248
103 UMBILICAL CORD ABNORMALITY 13 0.0247
104 LOW SET EARS 10 0.0243
105 NEONATAL DISORDER 38 0.0240
106 ALPHA 1 FOETOPROTEIN INCREASED 17 0.0239
107 TRISOMY 18 9 0.0236
108 MACROCYTOSIS 27 0.0233
109 BLIGHTED OVUM 9 0.0229
110 KIDNEY MALFORMATION 8 0.0227
111 CONGENITAL EYE DISORDER 6 0.0225
112 IMMUNE RECONSTITUTION SYNDROME 29 0.0225
113 FOETAL CARDIAC DISORDER 7 0.0222
114 PAPILLOMA 7 0.0221
115 SKULL MALFORMATION 14 0.0218
116 SINGLE UMBILICAL ARTERY 8 0.0217
117 NEONATAL ASPIRATION 7 0.0213
118 HYDROPS FOETALIS 13 0.0212
119 PLACENTAL INSUFFICIENCY 17 0.0212
120 ARNOLD-CHIARI MALFORMATION 20 0.0210
121 VIROLOGIC FAILURE 112 0.0208
122 VANISHING BILE DUCT SYNDROME 23 0.0206
123 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 14 0.0206
124 POLYHYDRAMNIOS 21 0.0206
125 ACUTE HIV INFECTION 5 0.0202
126 TWIN PREGNANCY 17 0.0202
127 FALLOT'S TETRALOGY 7 0.0202
128 ABORTION INDUCED 188 0.0199
129 SPINA BIFIDA 41 0.0197
130 HEAD DEFORMITY 6 0.0196
131 EAR MALFORMATION 9 0.0194
132 ANHEDONIA 504 0.0192
133 LIMB MALFORMATION 15 0.0190
134 CONGENITAL HAND MALFORMATION 13 0.0190
135 PREMATURE SEPARATION OF PLACENTA 29 0.0188
136 CUSHING'S SYNDROME 13 0.0187
137 FACIAL WASTING 5 0.0186
138 FOETAL ARRHYTHMIA 5 0.0186
139 GONORRHOEA 5 0.0185
140 MICROGNATHIA 9 0.0180
141 KAPOSI'S SARCOMA 9 0.0179
142 MICROCEPHALY 23 0.0179
143 BLOOD KETONE BODY INCREASED 14 0.0179
144 LIPOATROPHY 17 0.0179
145 LIPOEDEMA 7 0.0178
146 PYELOCALIECTASIS 17 0.0177
147 LIPOHYPERTROPHY 11 0.0177
148 ANKYLOGLOSSIA CONGENITAL 7 0.0174
149 ACQUIRED IMMUNODEFICIENCY SYNDROME 9 0.0173
150 SPINE MALFORMATION 6 0.0173
151 NECROTISING ENTEROCOLITIS NEONATAL 7 0.0172
152 MITOCHONDRIAL TOXICITY 14 0.0171
153 ANTEPARTUM HAEMORRHAGE 7 0.0169
154 BRAIN MALFORMATION 6 0.0168
155 SCLERAL DISCOLOURATION 11 0.0168
156 FOETAL DISORDER 14 0.0167
157 BLOOD HIV RNA INCREASED 30 0.0165
158 PULMONARY ARTERY STENOSIS CONGENITAL 12 0.0164
159 T-LYMPHOCYTE COUNT DECREASED 11 0.0161
160 FOETAL DISTRESS SYNDROME 34 0.0160
161 FOETAL HEART RATE ABNORMAL 14 0.0151
162 BENIGN HYDATIDIFORM MOLE 5 0.0151
163 ANAL ATRESIA 8 0.0150
164 SPEECH DISORDER DEVELOPMENTAL 43 0.0150
165 FOLATE DEFICIENCY 17 0.0147
166 GENE MUTATION 29 0.0146
167 HYPERLACTACIDAEMIA 39 0.0145
168 PRE-ECLAMPSIA 69 0.0145
169 CAESAREAN SECTION 169 0.0145
170 TALIPES 45 0.0145
171 LIVE BIRTH 120 0.0143
172 PREMATURE LABOUR 80 0.0141
173 CEREBRAL TOXOPLASMOSIS 13 0.0139
174 AMNIOTIC CAVITY INFECTION 10 0.0138
175 ECLAMPSIA 5 0.0136
176 ANAEMIA MEGALOBLASTIC 6 0.0135
177 CONGENITAL NOSE MALFORMATION 7 0.0132
178 CD4 LYMPHOCYTES DECREASED 28 0.0131
179 DEATH NEONATAL 18 0.0129
180 PLACENTA PRAEVIA 10 0.0127
181 MATERNAL DRUGS AFFECTING FOETUS 97 0.0126
182 POOR SUCKING REFLEX 5 0.0126
183 PULMONARY VALVE STENOSIS 10 0.0125
184 FANCONI SYNDROME ACQUIRED 22 0.0125
185 ECONOMIC PROBLEM 189 0.0125
186 SEPSIS NEONATAL 10 0.0123
187 BONE MARROW DEPRESSION 12 0.0123
188 PREMATURE BABY 363 0.0120
189 FOETAL MALFORMATION 13 0.0120
190 VENTRICULAR SEPTAL DEFECT 68 0.0119
191 PATENT DUCTUS ARTERIOSUS 47 0.0118
192 CERVICAL INCOMPETENCE 6 0.0118
193 CORONARY ARTERY ATHEROSCLEROSIS 5 0.0118
194 NORMAL NEWBORN 64 0.0118
195 CYTOLYTIC HEPATITIS 39 0.0117
196 OSTEOPENIA 178 0.0117
197 PROTHROMBIN LEVEL DECREASED 11 0.0117
198 SMALL FOR DATES BABY 57 0.0115
199 DYSMORPHISM 27 0.0115
200 HELLP SYNDROME 7 0.0114
201 BLOOD AMYLASE INCREASED 19 0.0111
202 UTERINE DILATION AND CURETTAGE 10 0.0111
203 ABORTION SPONTANEOUS 443 0.0110
204 BONE MARROW TOXICITY 13 0.0110
205 PATHOGEN RESISTANCE 100 0.0110
206 LYMPH NODE TUBERCULOSIS 8 0.0108
207 ADRENAL SUPPRESSION 9 0.0107
208 RENAL TUBULAR DYSFUNCTION 6 0.0106
209 BLOOD LACTIC ACID INCREASED 55 0.0104
210 HYPERBILIRUBINAEMIA NEONATAL 6 0.0103
211 SUDDEN INFANT DEATH SYNDROME 5 0.0102
212 BRAIN HERNIATION 30 0.0100
213 NEONATAL ASPHYXIA 7 0.0099
214 DRUG EXPOSURE BEFORE PREGNANCY 10 0.0099
215 HYPERTRIGLYCERIDAEMIA 57 0.0097
216 PREGNANCY 194 0.0097
217 HEMIANOPIA HOMONYMOUS 7 0.0095
218 FOETAL GROWTH RESTRICTION 58 0.0095
219 CONVULSION NEONATAL 5 0.0095
220 ABORTION MISSED 12 0.0094
221 NECROTISING RETINITIS 6 0.0094
222 CHLAMYDIAL INFECTION 7 0.0093
223 TOXOPLASMOSIS 10 0.0093
224 DRUG EXPOSURE VIA BREAST MILK 10 0.0091
225 LARGE FOR DATES BABY 8 0.0091
226 FOETAL DEATH 47 0.0091
227 CYTOGENETIC ABNORMALITY 10 0.0089
228 FOETAL EXPOSURE DURING PREGNANCY 720 0.0088
229 CEREBRAL CYST 6 0.0087
230 HYPOSPADIAS 18 0.0086
231 CONGENITAL ANOMALY 66 0.0085
232 CARDIAC MURMUR 73 0.0084
233 SYNDACTYLY 7 0.0084
234 PITTING OEDEMA 5 0.0082
235 ATTENTION DEFICIT HYPERACTIVITY DISORDER 34 0.0081
236 MULTIPLE-DRUG RESISTANCE 25 0.0081
237 CLEFT LIP 7 0.0080
238 RENAL COLIC 18 0.0080
239 VAGINITIS BACTERIAL 5 0.0079
240 LOW BIRTH WEIGHT BABY 62 0.0078
241 OLIGOHYDRAMNIOS 26 0.0078
242 GESTATIONAL DIABETES 37 0.0078
243 CLEFT PALATE 15 0.0078
244 ATRIAL SEPTAL DEFECT 65 0.0078
245 CYTOMEGALOVIRUS CHORIORETINITIS 15 0.0077
246 ASEPTIC NECROSIS BONE 6 0.0077
247 ABDOMINAL INJURY 4 0.0077
248 FEEDING DISORDER NEONATAL 8 0.0076
249 MULTIPLE CONGENITAL ABNORMALITIES 11 0.0076
250 HEART DISEASE CONGENITAL 27 0.0076
251 PULMONARY HYPOPLASIA 6 0.0076
252 HIV TEST POSITIVE 5 0.0076
253 NEONATAL RESPIRATORY DISTRESS SYNDROME 25 0.0071
254 HYPOTONIA NEONATAL 11 0.0070
255 APGAR SCORE LOW 9 0.0070
256 HIV INFECTION 21 0.0070
257 VIRAL LOAD INCREASED 27 0.0069
258 FAT TISSUE INCREASED 10 0.0069
259 SYPHILIS 5 0.0069
260 RIGHT VENTRICULAR HYPERTROPHY 6 0.0066
261 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
262 HYDROCELE 7 0.0066
263 OSTEOPOROSIS 269 0.0065
264 OSTEOMALACIA 10 0.0065
265 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0065
266 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 32 0.0064
267 TRANSPOSITION OF THE GREAT VESSELS 5 0.0064
268 LIP DISCOLOURATION 8 0.0063
269 NECROTISING COLITIS 8 0.0063
270 DYSLIPIDAEMIA 32 0.0063
271 CLEFT LIP AND PALATE 7 0.0063
272 CUSHINGOID 20 0.0062
273 BONE DENSITY DECREASED 195 0.0062
274 GESTATIONAL HYPERTENSION 8 0.0062
275 ANAL CANCER 6 0.0062
276 DYSBIOSIS 5 0.0061
277 BRADYCARDIA FOETAL 5 0.0060
278 CONGENITAL CARDIOVASCULAR ANOMALY 5 0.0060
279 PYLORIC STENOSIS 5 0.0059
280 UNDERWEIGHT 11 0.0056
281 MUTISM 8 0.0055
282 CERVICAL DYSPLASIA 12 0.0055
283 END STAGE RENAL DISEASE 100 0.0055
284 STRABISMUS 16 0.0054
285 PNEUMOCYSTIS JIROVECI PNEUMONIA 12 0.0054
286 RENAL TUBULAR DISORDER 15 0.0053
287 ACROCHORDON 7 0.0053
288 PREMATURE DELIVERY 84 0.0053
289 CEREBRAL PALSY 5 0.0053
290 FACIAL ASYMMETRY 5 0.0052
291 ECTOPIC PREGNANCY 16 0.0052
292 COARCTATION OF THE AORTA 5 0.0052
293 HYDROCEPHALUS 28 0.0051
294 HEPATOSPLENOMEGALY 13 0.0051
295 MESENTERIC VEIN THROMBOSIS 5 0.0050
296 VENTRICULAR HYPERTROPHY 12 0.0048
297 DILATATION VENTRICULAR 10 0.0048
298 NEPHRITIS INTERSTITIAL 6 0.0047
299 PNEUMONIA PNEUMOCOCCAL 7 0.0047
300 EMOTIONAL DISTRESS 557 0.0046
301 ACQUIRED GENE MUTATION 6 0.0046
302 HEPATOMEGALY 45 0.0046
303 MULTIPLE FRACTURES 72 0.0044
304 HAEMANGIOMA 10 0.0043
305 QUALITY OF LIFE DECREASED 58 0.0043
306 CHRONIC KIDNEY DISEASE 327 0.0043
307 ECHOCARDIOGRAM ABNORMAL 6 0.0043
308 MATERNAL EXPOSURE DURING PREGNANCY 381 0.0043
309 DECREASED ACTIVITY 46 0.0043
310 HEPATITIS TOXIC 11 0.0042
311 HYPERBILIRUBINAEMIA 43 0.0041
312 HYDRONEPHROSIS 31 0.0041
313 EXPOSURE DURING PREGNANCY 257 0.0041
314 ELECTROENCEPHALOGRAM ABNORMAL 13 0.0041
315 PREGNANCY ON CONTRACEPTIVE 6 0.0041
316 HEPATITIS 105 0.0041
317 APLASIA PURE RED CELL 14 0.0041
318 BLOOD UREA DECREASED 5 0.0040
319 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0040
320 MUSCLE CRAMP 7 0.0039
321 NON-HODGKIN'S LYMPHOMA 5 0.0038
322 LIPASE INCREASED 29 0.0038
323 OESOPHAGEAL CANDIDIASIS 15 0.0038
324 PULMONARY TUBERCULOSIS 16 0.0037
325 ABDOMINAL HERNIA 17 0.0037
326 RESPIRATORY DISORDER NEONATAL 6 0.0037
327 CORNEAL OPACITY 5 0.0037
328 APLASTIC ANAEMIA 19 0.0036
329 CENTRAL NERVOUS SYSTEM LYMPHOMA 5 0.0036
330 HYPERPARATHYROIDISM SECONDARY 9 0.0036
331 BLOOD LACTATE DEHYDROGENASE INCREASED 56 0.0035
332 BONE LOSS 52 0.0035
333 ATAXIA 41 0.0035
334 MENINGITIS CRYPTOCOCCAL 6 0.0034
335 BILIRUBIN CONJUGATED INCREASED 8 0.0034
336 HYPOTONIA 34 0.0034
337 GROWTH RETARDATION 10 0.0034
338 HEPATITIS FULMINANT 10 0.0034
339 INTELLECTUAL DISABILITY 5 0.0033
340 GENITAL HERPES 5 0.0033
341 PORTAL HYPERTENSION 10 0.0032
342 LOBAR PNEUMONIA 6 0.0032
343 NEPHROPATHY 30 0.0032
344 PSYCHOMOTOR RETARDATION 9 0.0032
345 DRUG RESISTANCE 82 0.0032
346 JAUNDICE NEONATAL 6 0.0032
347 FAECES PALE 7 0.0031
348 HYPERTONIA 18 0.0031
349 OSTEOPOROTIC FRACTURE 6 0.0031
350 EXERCISE TOLERANCE DECREASED 18 0.0031
351 CONGESTIVE CARDIOMYOPATHY 13 0.0031
352 DEVELOPMENTAL DELAY 28 0.0031
353 HEPATOCELLULAR DAMAGE 7 0.0031
354 LEUKOCYTOCLASTIC VASCULITIS 5 0.0031
355 HISTIOCYTOSIS HAEMATOPHAGIC 9 0.0030
356 ANGIONEUROTIC OEDEMA 8 0.0030
357 OCULAR ICTERUS 13 0.0030
358 JAUNDICE 80 0.0030
359 HEPATOTOXICITY 65 0.0029
360 RADIUS FRACTURE 7 0.0029
361 HYPERPARATHYROIDISM 6 0.0029
362 OSTEONECROSIS 93 0.0028
363 HISTOPLASMOSIS 5 0.0028
364 PROTEIN URINE PRESENT 14 0.0028
365 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
366 SCHIZOAFFECTIVE DISORDER 5 0.0028
367 VENTRICULAR HYPOKINESIA 9 0.0028
368 NAIL DISCOLOURATION 11 0.0028
369 CEREBELLAR SYNDROME 6 0.0027
370 TOOTH LOSS 56 0.0027
371 PARESIS 6 0.0027
372 PROTEINURIA 50 0.0026
373 BLOOD BILIRUBIN INCREASED 71 0.0026
374 SKIN ATROPHY 15 0.0026
375 LIP OEDEMA 11 0.0026
376 NEPHROGENIC ANAEMIA 12 0.0026
377 WRIST FRACTURE 31 0.0026
378 ATROPHY 5 0.0026
379 UMBILICAL HERNIA 12 0.0026
380 HAEMOLYTIC ANAEMIA 23 0.0026
381 PYELONEPHRITIS ACUTE 5 0.0025
382 BLOOD CREATINE PHOSPHOKINASE INCREASED 73 0.0025
383 RASH MACULO-PAPULAR 55 0.0025
384 RENAL MASS 5 0.0024
385 SKELETAL INJURY 25 0.0024
386 BONE DENSITY ABNORMAL 9 0.0024
387 ANAEMIA 453 0.0024
388 CLAVICLE FRACTURE 9 0.0023
389 AORTIC ARTERIOSCLEROSIS 6 0.0023
390 ENCEPHALITIS 16 0.0023
391 HYPERREFLEXIA 8 0.0023
392 PERSONALITY DISORDER 6 0.0023
393 GASTROENTERITIS 33 0.0023
394 HAND FRACTURE 16 0.0023
395 CHOLANGITIS 14 0.0023
396 STEVENS-JOHNSON SYNDROME 50 0.0022
397 RENAL TUBULAR NECROSIS 22 0.0022
398 METABOLIC DISORDER 13 0.0022
399 ALANINE AMINOTRANSFERASE INCREASED 137 0.0022
400 ASPARTATE AMINOTRANSFERASE INCREASED 118 0.0022
401 SPLENOMEGALY 26 0.0022
402 ORTHOPNOEA 7 0.0022
403 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
404 SPINAL COMPRESSION FRACTURE 18 0.0022
405 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
406 ANOREXIA 28 0.0022
407 APHTHOUS STOMATITIS 5 0.0022
408 PORTAL VEIN THROMBOSIS 7 0.0022
409 RENAL IMPAIRMENT 181 0.0022
410 DIABETIC COMA 6 0.0021
411 TOXIC EPIDERMAL NECROLYSIS 32 0.0021
412 PYELONEPHRITIS 18 0.0021
413 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
414 FOOT FRACTURE 39 0.0021
415 APLASIA 4 0.0020
416 HYPOPHOSPHATAEMIA 15 0.0020
417 LIVER FUNCTION TEST ABNORMAL 59 0.0020
418 RENAL FAILURE 269 0.0020
419 TRANSAMINASES INCREASED 45 0.0020
420 DYSSTASIA 59 0.0020
421 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 97 0.0020
422 ANGINA UNSTABLE 13 0.0020
423 ANXIETY 568 0.0020
424 HEPATITIS CHOLESTATIC 12 0.0020
425 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
426 AMMONIA INCREASED 10 0.0020
427 MEAN CELL VOLUME INCREASED 5 0.0019
428 BLOOD CREATININE INCREASED 127 0.0019
429 RENAL TRANSPLANT 7 0.0019
430 AMYLASE INCREASED 7 0.0019
431 CARDIOMYOPATHY 28 0.0019
432 NASAL DISORDER 5 0.0019
433 HYPERCHOLESTEROLAEMIA 18 0.0019
434 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
435 HEPATIC NECROSIS 7 0.0019
436 RESPIRATORY DISTRESS 51 0.0018
437 BACTERIAL SEPSIS 6 0.0018
438 DRUG TOXICITY 25 0.0018
439 HEPATOCELLULAR INJURY 26 0.0018
440 ACIDOSIS 14 0.0018
441 PANCYTOPENIA 102 0.0018
442 PULMONARY HYPERTENSION 38 0.0018
443 ORAL CANDIDIASIS 24 0.0018
444 DRUG SCREEN FALSE POSITIVE 5 0.0018
445 RIB FRACTURE 37 0.0018
446 CARDIOMEGALY 22 0.0018
447 PALLOR 48 0.0018
448 PHLEBITIS 9 0.0018
449 CANDIDIASIS 7 0.0017
450 ANKLE FRACTURE 27 0.0017
451 VITAMIN B12 DEFICIENCY 7 0.0017
452 EYELID OEDEMA 20 0.0017
453 TIBIA FRACTURE 8 0.0017
454 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
455 CREPITATIONS 5 0.0017
456 FAECAL INCONTINENCE 8 0.0017
457 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
458 HEPATITIS C 20 0.0017
459 VARICES OESOPHAGEAL 5 0.0017
460 RENAL CYST 13 0.0016
461 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
462 PANCREATIC DISORDER 8 0.0016
463 STAPHYLOCOCCAL SEPSIS 8 0.0016
464 RENAL PAIN 17 0.0016
465 CORONARY ARTERY STENOSIS 8 0.0016
466 TREATMENT NONCOMPLIANCE 86 0.0016
467 FEMORAL NECK FRACTURE 8 0.0016
468 MYOSITIS 14 0.0016
469 VITAMIN D DEFICIENCY 15 0.0015
470 PLATELET COUNT INCREASED 20 0.0015
471 NEPHROLITHIASIS 70 0.0015
472 RENAL INJURY 45 0.0015
473 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
474 HEPATIC STEATOSIS 28 0.0015
475 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
476 LEUKOPENIA 75 0.0015
477 AREFLEXIA 4 0.0015
478 RHINITIS 12 0.0015
479 INTERNATIONAL NORMALISED RATIO DECREASED 6 0.0015
480 ASCITES 43 0.0015
481 BRONCHOPNEUMONIA 5 0.0015
482 CYSTIC FIBROSIS 8 0.0014
483 THROMBOPHLEBITIS 5 0.0014
484 NEPHROPATHY TOXIC 16 0.0014
485 HYPERLIPIDAEMIA 17 0.0014
486 HYPOALBUMINAEMIA 11 0.0014
487 CHOLESTASIS 27 0.0014
488 LUNG NEOPLASM 6 0.0014
489 TEARFULNESS 6 0.0014
490 DRUG SCREEN POSITIVE 11 0.0014
491 BLOOD URIC ACID INCREASED 8 0.0014
492 HEPATITIS ACUTE 9 0.0014
493 HERPES SIMPLEX 9 0.0014
494 TRICUSPID VALVE INCOMPETENCE 11 0.0014
495 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
496 ABORTION 4 0.0014
497 CACHEXIA 7 0.0014
498 MALABSORPTION 7 0.0013
499 HEPATIC CIRRHOSIS 25 0.0013
500 HEPATITIS B 8 0.0013
501 SERUM FERRITIN INCREASED 7 0.0013
502 HEPATIC FAILURE 40 0.0013
503 TACHYPNOEA 18 0.0013
504 CYTOMEGALOVIRUS INFECTION 22 0.0013
505 COMMUNICATION DISORDER 5 0.0013
506 LACTIC ACIDOSIS 42 0.0013
507 TOXIC SKIN ERUPTION 13 0.0013
508 HEPATIC ENCEPHALOPATHY 12 0.0013
509 RASH GENERALISED 33 0.0013
510 MYOPATHY 11 0.0013
511 RENAL FAILURE ACUTE 54 0.0013
512 LYMPHADENOPATHY 45 0.0013
513 SKIN PAPILLOMA 5 0.0012
514 GOITRE 5 0.0012
515 VISUAL DISTURBANCE 7 0.0012
516 HERPES VIRUS INFECTION 7 0.0012
517 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
518 POST-TRAUMATIC STRESS DISORDER 8 0.0012
519 TOOTH FRACTURE 13 0.0012
520 BUNDLE BRANCH BLOCK LEFT 5 0.0012
521 DEPRESSION 267 0.0012
522 HAEMATOTOXICITY 11 0.0012
523 AORTIC STENOSIS 4 0.0011
524 EOSINOPHILIA 20 0.0011
525 SPINAL OSTEOARTHRITIS 10 0.0011
526 PNEUMOTHORAX 18 0.0011
527 PHARYNGOLARYNGEAL PAIN 6 0.0011
528 DRUG ERUPTION 20 0.0011
529 NERVOUS SYSTEM DISORDER 35 0.0011
530 PANCREATITIS ACUTE 25 0.0011
531 MULTIPLE INJURIES 7 0.0011
532 LUMBAR VERTEBRAL FRACTURE 5 0.0011
533 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
534 VAGINAL DISCHARGE 11 0.0011
535 BONE MARROW FAILURE 22 0.0011
536 IMPAIRED WORK ABILITY 23 0.0011
537 HAEMODIALYSIS 9 0.0011
538 NEUTROPENIA 145 0.0011
539 AUTOIMMUNE THYROIDITIS 4 0.0011
540 UPPER LIMB FRACTURE 21 0.0011
541 SPINAL FRACTURE 21 0.0010
542 HYPERTHERMIA 8 0.0010
543 CYST 13 0.0010
544 FRACTURE 19 0.0010
545 HEPATIC ENZYME ABNORMAL 5 0.0010
546 AZOTAEMIA 4 0.0010
547 HAEMOGLOBIN DECREASED 102 0.0010
548 NERVE INJURY 11 0.0010
549 PATHOLOGICAL FRACTURE 5 0.0010
550 MULTI-ORGAN FAILURE 17 0.0010
551 PAIN 601 0.0010
552 DRUG ABUSER 6 0.0010
553 UROSEPSIS 9 0.0010
554 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 8 0.0010
555 MAJOR DEPRESSION 7 0.0010
556 FACE OEDEMA 16 0.0009
557 SUDDEN DEATH 10 0.0009
558 CHROMATURIA 21 0.0009
559 DEAFNESS UNILATERAL 5 0.0009
560 ADRENAL INSUFFICIENCY 11 0.0009
561 ABNORMAL DREAMS 25 0.0009
562 ABDOMINAL DISTENSION 94 0.0009
563 HYPOCALCAEMIA 17 0.0009
564 INTRACRANIAL PRESSURE INCREASED 5 0.0009
565 MOBILITY DECREASED 64 0.0009
566 ACUTE KIDNEY INJURY 136 0.0009
567 LOWER LIMB FRACTURE 17 0.0009
568 LABORATORY TEST ABNORMAL 26 0.0009
569 RENAL DISORDER 41 0.0009
570 DRUG INTERACTION 138 0.0009
571 VENTRICULAR EXTRASYSTOLES 9 0.0009
572 MUSCLE DISORDER 7 0.0009
573 HEPATIC ENZYME INCREASED 58 0.0008
574 POLLAKIURIA 35 0.0008
575 GOUT 15 0.0008
576 DERMATITIS BULLOUS 6 0.0008
577 HYPERKALAEMIA 29 0.0008
578 CYANOSIS 13 0.0008
579 OSTEOARTHRITIS 35 0.0008
580 PYREXIA 285 0.0008
581 CHOLELITHIASIS 27 0.0008
582 BONE DISORDER 15 0.0008
583 DYSPNOEA EXERTIONAL 31 0.0008
584 ORAL DISORDER 6 0.0008
585 FEAR 22 0.0008
586 PSYCHOTIC DISORDER 24 0.0008
587 CONJUNCTIVITIS 15 0.0008
588 SLEEP DISORDER 57 0.0008
589 ABDOMINAL TENDERNESS 4 0.0008
590 DIABETES MELLITUS 61 0.0008
591 PANCREATITIS 42 0.0008
592 MUSCLE ATROPHY 10 0.0008
593 GASTROINTESTINAL DISORDER 70 0.0008
594 RENAL FAILURE CHRONIC 6 0.0008
595 LYMPHOPENIA 11 0.0008
596 HAEMOLYSIS 6 0.0008
597 CONVULSION 44 0.0008
598 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
599 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
600 FURUNCLE 6 0.0008
601 POLYNEUROPATHY 9 0.0008
602 MENINGITIS 5 0.0007
603 FLANK PAIN 7 0.0007
604 GAIT DISTURBANCE 140 0.0007
605 EYE MOVEMENT DISORDER 5 0.0007
606 HYPONATRAEMIA 41 0.0007
607 AFFECT LABILITY 7 0.0007
608 LYMPHOEDEMA 5 0.0007
609 FOOT DEFORMITY 8 0.0007
610 DERMATITIS ALLERGIC 9 0.0007
611 THROMBOCYTOPENIA 80 0.0007
612 ANGIOPATHY 4 0.0007
613 MITRAL VALVE INCOMPETENCE 8 0.0007
614 HAEMATURIA 24 0.0007
615 NEUTROPENIC SEPSIS 5 0.0007
616 NIGHTMARE 24 0.0007
617 PERICARDIAL EFFUSION 16 0.0007
618 BLOOD CHOLESTEROL INCREASED 32 0.0007
619 SEPSIS 76 0.0007
620 LUNG INFILTRATION 6 0.0007
621 LIVER DISORDER 30 0.0007
622 OPTIC NEURITIS 6 0.0007
623 BRAIN NEOPLASM 6 0.0007
624 HIP ARTHROPLASTY 10 0.0007
625 RESPIRATORY DEPRESSION 8 0.0007
626 NEUROPATHY PERIPHERAL 62 0.0007
627 ENCEPHALOPATHY 16 0.0007
628 RHABDOMYOLYSIS 27 0.0006
629 GASTRITIS 17 0.0006
630 BACK INJURY 7 0.0006
631 APNOEA 5 0.0006
632 BLOOD SODIUM DECREASED 12 0.0006
633 C-REACTIVE PROTEIN INCREASED 23 0.0006
634 HYPERGLYCAEMIA 23 0.0006
635 OEDEMA 34 0.0006
636 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
637 RASH PAPULAR 14 0.0006
638 GLAUCOMA 12 0.0006
639 HYPOKINESIA 9 0.0006
640 MYOCARDIAL ISCHAEMIA 7 0.0006
641 POLYURIA 5 0.0006
642 EATING DISORDER 13 0.0006
643 IMMUNE SYSTEM DISORDER 8 0.0006
644 ACUTE CORONARY SYNDROME 5 0.0006
645 VISUAL ACUITY REDUCED 20 0.0006
646 BONE PAIN 35 0.0006
647 METABOLIC ACIDOSIS 19 0.0006
648 EYELID PTOSIS 6 0.0006
649 HEMIPARESIS 10 0.0006
650 MOTOR DYSFUNCTION 6 0.0006
651 CHOLECYSTITIS 7 0.0006
652 METRORRHAGIA 10 0.0006
653 GENERAL PHYSICAL HEALTH DETERIORATION 67 0.0006
654 ACUTE MYELOID LEUKAEMIA 9 0.0006
655 NOCTURIA 7 0.0006
656 PURPURA 5 0.0006
657 RASH ERYTHEMATOUS 27 0.0006
658 RESPIRATORY RATE INCREASED 5 0.0006
659 ANGINA PECTORIS 16 0.0006
660 POISONING 7 0.0006
661 HAEMATOCRIT DECREASED 11 0.0006
662 HYPERTHYROIDISM 8 0.0006
663 PNEUMONIA BACTERIAL 5 0.0005
664 GRAND MAL CONVULSION 5 0.0005
665 SKIN DISORDER 18 0.0005
666 ERYTHEMA MULTIFORME 5 0.0005
667 DEAFNESS 14 0.0005
668 ABNORMAL BEHAVIOUR 21 0.0005
669 OEDEMA PERIPHERAL 64 0.0005
670 EPILEPSY 16 0.0005
671 PARANOIA 9 0.0005
672 ASTHENIA 196 0.0005
673 DYSURIA 19 0.0005
674 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
675 ACUTE MYOCARDIAL INFARCTION 15 0.0005
676 VERTIGO 31 0.0005
677 PRODUCT USE COMPLAINT 8 0.0005
678 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
679 COORDINATION ABNORMAL 7 0.0005
680 MASS 7 0.0005
681 ABDOMINAL PAIN 116 0.0005
682 HYPOKALAEMIA 23 0.0005
683 VOMITING 234 0.0005
684 HIP FRACTURE 16 0.0005
685 CORONARY ARTERY DISEASE 15 0.0005
686 HYPOGLYCAEMIA 24 0.0005
687 EUPHORIC MOOD 5 0.0005
688 HYPERTENSION 103 0.0005
689 TENDON RUPTURE 6 0.0005
690 DRUG LEVEL INCREASED 8 0.0005
691 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
692 COAGULOPATHY 8 0.0005
693 INCONTINENCE 5 0.0005
694 MUSCULOSKELETAL DISORDER 9 0.0005
695 LETHARGY 27 0.0005
696 RESPIRATORY DISORDER 14 0.0005
697 BODY HEIGHT DECREASED 5 0.0005
698 NEUTROPHIL COUNT DECREASED 19 0.0005
699 LIVER FUNCTION TEST INCREASED 10 0.0005
700 ANURIA 4 0.0005
701 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
702 BIPOLAR DISORDER 5 0.0005
703 LOCAL SWELLING 8 0.0005
704 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
705 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
706 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
707 EJECTION FRACTION DECREASED 7 0.0004
708 MALNUTRITION 5 0.0004
709 AMNESIA 29 0.0004
710 TYPE 2 DIABETES MELLITUS 15 0.0004
711 ILL-DEFINED DISORDER 27 0.0004
712 BODY TEMPERATURE INCREASED 9 0.0004
713 IMPAIRED GASTRIC EMPTYING 6 0.0004
714 OBESITY 7 0.0004
715 TACHYCARDIA 39 0.0004
716 MYOCARDITIS 5 0.0004
717 SKIN DISCOLOURATION 20 0.0004
718 HAEMATEMESIS 11 0.0004
719 AGRANULOCYTOSIS 8 0.0004
720 MOUTH ULCERATION 9 0.0004
721 DISTURBANCE IN ATTENTION 23 0.0004
722 ARTERIOSCLEROSIS 4 0.0004
723 DIALYSIS 6 0.0004
724 WEIGHT DECREASED 118 0.0004
725 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
726 FEMUR FRACTURE 13 0.0004
727 RED BLOOD CELL COUNT DECREASED 12 0.0004
728 ACUTE RESPIRATORY FAILURE 8 0.0004
729 ATELECTASIS 4 0.0004
730 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
731 SCHIZOPHRENIA 5 0.0004
732 HAEMORRHOIDS 8 0.0004
733 SCAR 7 0.0004
734 DEHYDRATION 54 0.0004
735 HEPATIC FUNCTION ABNORMAL 15 0.0004
736 CHILLS 47 0.0004
737 DEEP VEIN THROMBOSIS 26 0.0004
738 BLOOD POTASSIUM DECREASED 12 0.0004
739 RESPIRATORY FAILURE 29 0.0004
740 AGITATION 29 0.0004
741 INSOMNIA 105 0.0004
742 CARDIOVASCULAR DISORDER 10 0.0004
743 DRUG DISPENSING ERROR 6 0.0004
744 THIRST 7 0.0004
745 BACK PAIN 91 0.0004
746 SHOCK 9 0.0004
747 FLATULENCE 22 0.0004
748 LEUKOCYTOSIS 7 0.0004
749 CARDIAC FAILURE 31 0.0004
750 CARDIAC FAILURE CONGESTIVE 31 0.0004
751 CONFUSIONAL STATE 62 0.0004
752 ROAD TRAFFIC ACCIDENT 16 0.0004
753 DIARRHOEA 246 0.0004
754 HALLUCINATION, AUDITORY 6 0.0004
755 MYALGIA 64 0.0004
756 PALPITATIONS 44 0.0004
757 NIGHT SWEATS 12 0.0004
758 DYSPHAGIA 35 0.0004
759 VAGINAL HAEMORRHAGE 16 0.0004
760 LUNG DISORDER 18 0.0004
761 MOOD ALTERED 10 0.0004
762 LIVER INJURY 9 0.0004
763 MANIA 6 0.0004
764 PRESCRIBED OVERDOSE 7 0.0004
765 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
766 BRADYCARDIA 19 0.0004
767 BRONCHOSPASM 5 0.0004
768 SUICIDAL IDEATION 32 0.0003
769 INTENTIONAL SELF-INJURY 7 0.0003
770 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
771 MYELODYSPLASTIC SYNDROME 5 0.0003
772 RASH 150 0.0003
773 SPEECH DISORDER 18 0.0003
774 APATHY 5 0.0003
775 NAUSEA 270 0.0003
776 BACTERAEMIA 4 0.0003
777 FATIGUE 262 0.0003
778 COMA 16 0.0003
779 HAEMORRHAGE INTRACRANIAL 5 0.0003
780 MYOCARDIAL INFARCTION 58 0.0003
781 MENTAL IMPAIRMENT 8 0.0003
782 SUICIDE ATTEMPT 20 0.0003
783 DISORIENTATION 13 0.0003
784 TINNITUS 15 0.0003
785 PULMONARY EMBOLISM 31 0.0003
786 DRUG ADMINISTRATION ERROR 10 0.0003
787 LYMPHOMA 5 0.0003
788 WHITE BLOOD CELL COUNT DECREASED 35 0.0003
789 SEPTIC SHOCK 14 0.0003
790 BACTERIAL INFECTION 6 0.0003
791 BLISTER 18 0.0003
792 PHOTOPHOBIA 6 0.0003
793 HALLUCINATION 24 0.0003
794 BLOOD URINE PRESENT 6 0.0003
795 PRODUCTIVE COUGH 15 0.0003
796 MOOD SWINGS 10 0.0003
797 ORAL PAIN 7 0.0003
798 PLATELET COUNT DECREASED 33 0.0003
799 BLOOD POTASSIUM INCREASED 5 0.0003
800 SWELLING FACE 20 0.0003
801 STAPHYLOCOCCAL INFECTION 10 0.0003
802 COUGH 85 0.0003
803 ARTHRALGIA 126 0.0003
804 AGGRESSION 15 0.0003
805 HYPERSENSITIVITY 55 0.0003
806 ACUTE HEPATIC FAILURE 4 0.0003
807 PAIN IN EXTREMITY 86 0.0003
808 DIABETIC KETOACIDOSIS 7 0.0003
809 GYNAECOMASTIA 9 0.0003
810 PNEUMONIA 94 0.0003
811 MENTAL STATUS CHANGES 8 0.0003
812 DERMATITIS 6 0.0003
813 NEUROTOXICITY 5 0.0003
814 ABDOMINAL PAIN LOWER 7 0.0003
815 RASH PRURITIC 15 0.0003
816 FAECES DISCOLOURED 6 0.0003
817 MEMORY IMPAIRMENT 38 0.0003
818 MENTAL DISORDER 12 0.0003
819 CRYING 10 0.0003
820 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
821 SOMNOLENCE 55 0.0003
822 ERECTILE DYSFUNCTION 7 0.0003
823 DYSPNOEA 154 0.0003
824 INFLAMMATION 14 0.0003
825 SKIN ULCER 7 0.0003
826 BRONCHITIS 20 0.0003
827 CHEST PAIN 50 0.0003
828 TOOTH DISORDER 6 0.0003
829 NECK PAIN 15 0.0003
830 HEADACHE 168 0.0003
831 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
832 DYSARTHRIA 10 0.0003
833 GASTRIC ULCER 5 0.0003
834 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
835 NO ADVERSE EVENT 47 0.0003
836 RECTAL HAEMORRHAGE 11 0.0003
837 SKIN LESION 7 0.0003
838 RESPIRATORY ARREST 7 0.0003
839 HAEMATOCHEZIA 14 0.0003
840 HAEMOPTYSIS 7 0.0003
841 LOSS OF CONSCIOUSNESS 32 0.0002
842 DRUG INTOLERANCE 24 0.0002
843 INTERSTITIAL LUNG DISEASE 12 0.0002
844 PLEURAL EFFUSION 15 0.0002
845 DIZZINESS 121 0.0002
846 VIRAL INFECTION 8 0.0002
847 PNEUMONIA ASPIRATION 6 0.0002
848 FUNGAL INFECTION 8 0.0002
849 PRODUCT COMPLAINT 6 0.0002
850 RETCHING 5 0.0002
851 JOINT INJURY 5 0.0002
852 MEDICATION ERROR 13 0.0002
853 HYPOAESTHESIA 35 0.0002
854 INFLUENZA LIKE ILLNESS 19 0.0002
855 MALAISE 101 0.0002
856 HYPOXIA 8 0.0002
857 DEPRESSED MOOD 12 0.0002
858 HERPES ZOSTER 13 0.0002
859 ANGIOEDEMA 10 0.0002
860 HYPOTENSION 45 0.0002
861 DYSPEPSIA 22 0.0002
862 PULMONARY OEDEMA 10 0.0002
863 DRUG-INDUCED LIVER INJURY 7 0.0002
864 DRY MOUTH 18 0.0002
865 DYSKINESIA 9 0.0002
866 HYPOTHYROIDISM 7 0.0002
867 ACCIDENTAL OVERDOSE 8 0.0002
868 PRURITUS 84 0.0002
869 ABDOMINAL PAIN UPPER 45 0.0002
870 TREATMENT FAILURE 18 0.0002
871 IRRITABILITY 13 0.0002
872 FEELING COLD 6 0.0002
873 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
874 DECREASED APPETITE 50 0.0002
875 BURNING SENSATION 15 0.0002
876 MUSCULAR WEAKNESS 24 0.0002
877 SYNCOPE 21 0.0002
878 URINARY RETENTION 7 0.0002
879 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
880 GASTRIC DISORDER 7 0.0002
881 CARDIAC DISORDER 19 0.0002
882 URINARY INCONTINENCE 6 0.0002
883 URTICARIA 33 0.0002
884 DISCOMFORT 12 0.0002
885 HYPOPHAGIA 5 0.0002
886 CEREBRAL HAEMORRHAGE 7 0.0002
887 DIPLOPIA 5 0.0002
888 RESPIRATORY TRACT INFECTION 5 0.0002
889 ECZEMA 10 0.0002
890 ABDOMINAL DISCOMFORT 32 0.0002
891 ARRHYTHMIA 9 0.0002
892 VISION BLURRED 26 0.0002
893 CATARACT 11 0.0002
894 DIVERTICULITIS 5 0.0002
895 ANGER 6 0.0002
896 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
897 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
898 TREMOR 29 0.0002
899 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
900 HAEMORRHAGE 18 0.0002
901 BLINDNESS 7 0.0002
902 RASH MACULAR 6 0.0002
903 COGNITIVE DISORDER 8 0.0002
904 INFECTION 24 0.0002
905 PANIC ATTACK 6 0.0002
906 CONDITION AGGRAVATED 50 0.0002
907 RESTLESSNESS 6 0.0002
908 ABASIA 4 0.0002
909 CELLULITIS 8 0.0002
910 CARDIAC ARREST 13 0.0002
911 INJURY 11 0.0002
912 ADVERSE DRUG REACTION 14 0.0002
913 MOVEMENT DISORDER 5 0.0002
914 HYPERHIDROSIS 20 0.0002
915 NASAL CONGESTION 9 0.0002
916 MUSCLE SPASMS 28 0.0002
917 URINARY TRACT INFECTION 26 0.0002
918 EYE DISORDER 5 0.0002
919 HEART RATE INCREASED 15 0.0002
920 BLOOD PRESSURE INCREASED 23 0.0002
921 BALANCE DISORDER 13 0.0002
922 FEELING HOT 9 0.0001
923 CHEST DISCOMFORT 15 0.0001
924 CARDIO-RESPIRATORY ARREST 6 0.0001
925 ARTHRITIS 11 0.0001
926 PARAESTHESIA 22 0.0001
927 THROAT IRRITATION 6 0.0001
928 MUSCULOSKELETAL PAIN 7 0.0001
929 COLITIS 5 0.0001
930 CEREBROVASCULAR ACCIDENT 22 0.0001
931 WEIGHT INCREASED 29 0.0001
932 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
933 ANAPHYLACTIC REACTION 7 0.0001
934 DISEASE RECURRENCE 6 0.0001
935 MUSCULOSKELETAL STIFFNESS 11 0.0001
936 BLOOD GLUCOSE DECREASED 6 0.0001
937 TOXICITY TO VARIOUS AGENTS 21 0.0001
938 DEATH 107 0.0001
939 ERYTHEMA 25 0.0001
940 DYSGEUSIA 9 0.0001
941 ADVERSE EVENT 11 0.0001
942 SWELLING 11 0.0001
943 ALOPECIA 23 0.0001
944 SINUSITIS 12 0.0001
945 ATRIAL FIBRILLATION 11 0.0001
946 THROMBOSIS 9 0.0001
947 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
948 FALL 36 0.0001
949 ARTHROPATHY 6 0.0001
950 OXYGEN SATURATION DECREASED 6 0.0001
951 EYE PAIN 6 0.0001
952 BLOOD PRESSURE DECREASED 7 0.0001
953 OVERDOSE 22 0.0001
954 INJECTION SITE REACTION 7 0.0001
955 DRY EYE 5 0.0001
956 STOMATITIS 6 0.0001
957 SKIN EXFOLIATION 8 0.0001
958 DRUG INEFFECTIVE 122 0.0001
959 UNEVALUABLE EVENT 7 0.0001
960 CONSTIPATION 20 0.0001
961 DRUG DOSE OMISSION 15 0.0001
962 NEOPLASM MALIGNANT 6 0.0001
963 ASTHMA 10 0.0001
964 FEELING ABNORMAL 21 0.0001
965 PRODUCT SUBSTITUTION ISSUE 5 0.0001
966 WHEEZING 5 0.0001
967 JOINT SWELLING 10 0.0001
968 THERAPEUTIC RESPONSE DECREASED 5 0.0001
969 VISUAL IMPAIRMENT 10 0.0001
970 EPISTAXIS 6 0.0001
971 BLOOD GLUCOSE INCREASED 15 0.0001
972 SEIZURE 9 0.0001
973 DRY SKIN 10 0.0001
974 MIGRAINE 7 0.0001
975 CONTUSION 7 0.0001
976 PERIPHERAL SWELLING 11 0.0001
977 HOT FLUSH 5 0.0001
978 OROPHARYNGEAL PAIN 6 0.0001
979 PROSTATE CANCER 5 0.0001
980 PRODUCT QUALITY ISSUE 7 0.0001
981 DISEASE PROGRESSION 6 0.0001
982 HOSPITALISATION 7 0.0000
983 INFLUENZA 5 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
985 PSORIASIS 5 0.0000
986 NASOPHARYNGITIS 7 0.0000
987 OFF LABEL USE 32 0.0000
988 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
989 INCORRECT DOSE ADMINISTERED 6 0.0000
990 INJECTION SITE PAIN 7 0.0000